Cancer-Derived Exosomal miR-651 as a Diagnostic Marker Restrains Cisplatin Resistance and Directly Targets ATG3 for Cervical Cancer - Zhu, Xiaofan; Long, Ling; Xiao, He; He, Xuan (Disease markers, 2021)
Keywords: Antineoplastic Agents - pharmacology; Apoptosis; Autophagy-Related Proteins - genetics; Autophagy-Related Proteins - metabolism; Biomarkers, Tumor - genetics; Biomarkers, Tumor - metabolism; Cancer; Cancer therapies; CD63 antigen; CD81 antigen; CD9 antigen; Cell culture; Cell Proliferation; Cervical cancer; Cervix; Chemical compounds; Chemotherapy; Cisplatin; Cisplatin - pharmacology; Diagnostic systems; Drug resistance; Drug Resistance, Neoplasm; Exosomes; Exosomes - genetics; Female; Gene Expression Regulation, Neoplastic; Humans; Membranes; MicroRNAs; MicroRNAs - genetics; Pharmacology; Prognosis; Proteins; Radiation therapy; Surgery; Tumor Cells, Cultured; Tumors; Ubiquitin-Conjugating Enzymes - genetics; Ubiquitin-Conjugating Enzymes - metabolism; Uterine Cervical Neoplasms - drug therapy; Uterine Cervical Neoplasms - genetics; Uterine Cervical Neoplasms - metabolism; Uterine Cervical Neoplasms - pathology; United States--US; China; Japan